Searchable abstracts of presentations at key conferences in endocrinology

ea0007s21 | Neural migration in neuroendocrine systems | BES2004

GnRH neuronal Ontogeny - lessons from the investigation of Kallmann's Syndrome

Bouloux P , Hu Y , Kim S , Martinez|#Gonzalez D

The defining features of Kallmann's syndrome (KS) are isolated hypogonadotrophic hypogonadism (IHH) and anosmia, the consequences of a GnRH neuronal migratory defect and olfactory bulb agenesis respectively. Additional features in X-linked Kallmann's syndrome (XKI), include unilateral renal agenesis and bimanual synkinesis respectively. XKI results from mutations of KALIG 1, on Xp22.3. The encoded protein anosmin-1, is a hexamodular secreted cell membrane associated extracellu...

ea0009p129 | Endocrine tumours and neoplasia | BES2005

Telomerase-mediated immortalisation of human embryonic olfactory GnRH neuroblasts

Kim S , Gonzalez D , Brazma D , Hu Y , Peters G , Bouloux P

During early embryogenesis, the olfactory axons and gonadotrophin-releasing hormone(GnRH)-secreting neurons undergo dynamic processes of differentiation, migration and proliferation, regulated by a complex network of molecular and cellular mechanisms responding to various hormonal and developmental signals. Mutations in anosmin-1 and FGFR1 disrupt this pathway, causing Kallmann's syndrome(KS), a human hereditary disorder with GnRH deficiency and inability to smell. A primary n...

ea0070aep1054 | Hot topics (including COVID-19) | ECE2020

A pilot trial for silymarin in prediabetic patients with preclinical liver disease: Focus on insulin resistance

Javier Martinez-Martin Francisco , Kuzior Agnieszka , Maria Fernandez-Trujillo-Comenge Paula , Hernandez-Lazaro Alba , Quintana-Arroyo Sara , Arnas-Leon Claudia , Acosta-Calero Carmen , Gonzalez Díaz Paula , Perdomo-Herrera Esperanza , Lucía Tocino-Hernandez Alba

Introduction: Silymarin is a standardized extract of the milk thistle (Sylibum marianum) seeds, containing a mixture of flavonolignans: silybinin, isosilybinin, silycristin, silydianin, and others. It is used in the treatment of toxic liver damage and as adjunctive therapy in chronic hepatitis and cirrhosis. Recent studies have shown a potential benefit in the treatment of diabetes mellitus and non-alcoholic fatty liver disease. We undertook to study the effect of silymarin on...